SURVIVORSHIP PROGRAM: SECOND MALIGNANCIES IN LYMPHOMA SURVIVORS

EHA Library, Maria Pina Simula, 134754

GEMCITABIN, VINORELBINE AND PREDNISOLONE (GVP)

EHA Library, Semra Paydas, 134755

LYMPHADENOPATHY WITH ELEVATED IGG4 PLASMA CELLS IN CHILDHOOD: A POSSIBLE ASSOCIATION WITH MALIGNANCIES OR IMMUNE MEDIATED DISEASES

EHA Library, Maria Paola Boaro, 134756

LATE RELAPSE OF HODGKIN LYMPHOMA ? IS IT DIFFERENT IN CLINICAL CHARACTERISTICS AND OUTCOME?

EHA Library, Olivera Markovic, 134757

LYMPHOMA SURVIVORSHIP AND CARDIOVASCULAR DISEASES SURVEILLANCE

EHA Library, Maria Pina Simula, 134758

OSTEONECROSIS DETECTED BY WHOLE BODY MAGNETIC RESONANCE IN PATIENTS WITH HODGKIN LYMPHOMA TREATED BY BEACOPP

EHA Library, Caterina Patti, 134759

MORPHOLOGIC PATTERN AND PROGNOSTIC SIGNIFICANCE OF CD30 DISTRIBUTION WITHIN NEOPLASTIC CELLS IN HODGKIN LYMPHOMA.

EHA Library, Francesco Gaudio, 134760

EFFICACY AND SAFETY OF APREPITANT FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN PEDIATRIC PATIENTS

EHA Library, Rosanna Parasole, 134761

TCL1A EXPRESSION IN SPLENIC MARGINAL ZONE LYMPHOMAS (SMZL) AND CLONAL B-CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL-MZ): CORELLATION WITH IMMUNOPHENOTYPE, MYD88L265P EXPRESSION AND CLINICAL DATA

EHA Library, Christina Kalpadakis, 134762

DESCRIPTION OF LATE ONSET NEUTROPENIA IN PATIENTS TREATED WITH BENDAMUSTINE PLUS RITUXIMAB

EHA Library, Benjamin Verriere, 134763

IS THERE A REAL INCRESED PREVALENCE OF HEPATITIS B REACTIVATION IN PATIENTS WITH CD20+ INDOLENT NON HODGKIN LYMPHOMA DURING MAINTENANCE WITH RITUXIMAB?

EHA Library, Orsola Vitagliano, 134764

THE ABSOLUTE LYMPHOCYTE COUNT AS INDEPENDENT PARAMETER MAY PREDICT PROGNOSIS OF FOLLICULAR LYMPHOMA PATIENTS

EHA Library, Jelena Jelicic, 134765

PEGFILGRASTIM IN PRIMARY PROPHYLAXIS OF FEBRILE NEUTROPENIA DURING RITUXIMAB-BENDAMUSTINE TREATMENT IN INDOLENT NON HODGKIN LYMPHOMA : A REAL-LIFE EXPERIENCE

EHA Library, Claudio Cerchione, 134766

RISK OF HISTOLOGIC TRANSFORMATION (HT) IN SPLENIC MARGINAL ZONE LYMPHOMA (SMZL) PATIENTS TREATED WITH RITUXIMAB

EHA Library, Christina Kalpadakis, 134767

OUTCOMES OF INDOLENT LYMPHOMAS (INHL) IN THE ELDERLY - AN OBSERVATIONAL STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGICAL DISEASES

EHA Library, Dino Dujmovic, 134768

RESPONSE ASSESSMENT USING IWG2007 AND DEAUVILLE CRITERIA IN B-CELL NON-HODGKIN LYMPHOMA PATIENTS TREATED WITH 90Y-IT

EHA Library, Marcio Andrade-Campos, 134769

SHOULD STAGE I AND II FOLLICULAR LYMPHOMA BE TREATED EVEN IN THE RITUXIMAB ERA?

EHA Library, Dennisse Sharon Toral Ibarra, 134770

18FDG-PET ROLE OF IN THE EVALUATION OF BONE MARROW INFILTRATION IN PATIENTS WITH NHL

EHA Library, Fabio Trastulli, 134771

SUCCESSFUL SWITCH FROM INTRAVENOUS TO SUBCUTANEOUS RITUXIMAB AT THE ULSTER HOSPITAL, BELFAST, NORTHERN IRELAND

EHA Library, Richard Dillon, 134772

THERAPY AND LONG-TERM RESULTS OF HEPATITIS C-ASSOCIATED INDOLENT NON-HODGKIN LYMPHOMA

EHA Library, sergey lepkov, 134773

DURABLE RESPONSES WITH IDELALISIB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA (SLL)

EHA Library, Andrew J. Davies, 134774

INITIAL TREATMENT RESPONSE PREDICTS THE OUTCOME OF ELDERLY FOLLICULAR LYMPHOMA PATIENTS TREATED WITH IMMUNOCHEMOTHERAPY

EHA Library, Bosko Andjelic, 134775

DURABLE RESPONSES WITH IDELALISIB MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA (MZL)

EHA Library, E Gyan, 134776

THE STRUCTURE AND EFFICACY OF B-CELL LYMPHOMA'S REAL LIFE TREATMENT ACCORDING DATA OF THE REGIONAL SEGMENT OF THE RUSSIAN FEDERATION'S FEDERAL REGISTER

EHA Library, Svetlana Volkova, 134777

DETECTION OF MYD88 (L265P) SOMATIC MUTATION IN SPLENIC MARGINAL ZONE LYMPHOMA (SMZL)

EHA Library, Christina Kalpadakis, 134778

SIGNIFICANT ROLE OF FLOW CYTOMETRY IN THE DIAGNOSIS AND FOLLOW UP OF GASTRIC LNH

EHA Library, Serena Luponio, 134779

RESULTS OF LAPAROSCOPIC SPLENECTOMY IN SPLENOMEGALY

EHA Library, Olga Soboleva, 134780

BRAF GENE MUTATIONS AND PROGNOSTIC SIGNIFICANCE OF CLINICAL FINDINGS IN CASTLEMAN DISEASE

EHA Library, Mehmet Türker, 134781

OCULAR ADNEXAL LYMPHOMAS: A CASE SERIES

EHA Library, Saniya Dhawan, 134782

RISK FACTORS AND MICROBIOLOGICAL FEATURES OF BLOODSTREAM NONTYPHOIDAL SALMONELLA INFECTION IN ADULT PATIENTS RECEIVING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Po-Shen Ko, 134783

THE REAL WORLD USE OF BISPHOSPHONATES IN MULTIPLE MYELOMA AT UNIVERSITY COLLEGE HOSPITAL (UCH), LONDON: A COMPARISON WITH LATEST GUIDANCE

EHA Library, Oliver Cohen, 134784

ANTIFUNGAL PROPHYLAXIS WITH MICAFUNGIN IN PATIENTS UNDERGOING AUTOLOGOUS AND ALLOGENIC STEM CELL TRANSPLANTATION. A SINGLE CENTRE EXPERIENCE.

EHA Library, Alvaro Alba Sosa, 134785

THE POSITIVE IMPACT OF ANTIMICROBIAL STEWARDSHIP IN THE BIGGEST PEDIATRIC HAEMATOLOGY ONCOLOGY CENTRE, RUSSIA

EHA Library, Galina Solopova, 134786

INVESTIGATION OF RELATIONSHIP BETWEEN NEUTROPENIA AND SERUM CHITOTRIOSIDASE AND NEUTROPHIL GELATINASE RELATED LIPOCALIN ENZYME ACTIVITY IN CHILDREN UNDERGOING CHEMOTHERAPY

EHA Library, Orhan Gursel, 134787

EPIDEMIOLOGY OF FEBRILE EVENTS (FE) IN NEUTROPENIC PATIENTS (PTS) WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) TREATED BY

EHA Library, Vladimir Okhmat, 134788

THE CLINICAL SIGNIFICANCE OF PROCALCITONIN MONITORING IN INFECTED PATIENTS WITH HEMATOPATHY

EHA Library, Aining Sun, 134789

PREVALENCE OF CYTOPENIAS IN PATIENTS LIVING WITH THE HUMAN IMMUNODEFICIENCY VIRUS. AN OBSERVATIONAL COHORT STUDY.

EHA Library, Theofilo Miguel de Luca, 134790

IMMUNOGLOBULIN SUPPLEMENTATION IN ACUTE LYMPHOBLASTIC LEUKEMIA TREATMENT IN A SINGLE PEDIATRIC INSTITUTION: COMPARISON BETWEEN TWO CONSECUTIVE AIEOP CLINICAL TRIALS.

EHA Library, Rosanna Parasole, 134791

CANDIDAEMIA SPECTRUM: RESULTS OF A THREE-YEAR ANALYSIS AT THE PEDIATRIC HAEMATOLOGY ONCOLOGY CENTRE, RUSSIA

EHA Library, Valentina Pirumova, 134792

RISK FACTORS FOR INFECTION AND HIGH MORTALITY RATE AMONG PATIENTS WITH KPC PRODUCING KLEBSIELLA PNEUMONIAE BACTERAEMIAS IN A HAEMATOLOGY UNIT

EHA Library, ATHANASIOS Galanopoulos, 134793

PLASMA POSACONAZOLE CONCENTRATION DURING CONCOMITANT TREATMENT WITH PROTON PUMP INHIBITHOR OMEPRAZOLE IN ADOLESCENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT.

EHA Library, Michela Ribersani, 134794

A NOVEL MARKER FOR DIFFERENTIAL DIAGNOSIS BETWEEN HEPATITIS B AND HEPATITIS C USING ROUTINE COMPLETE BLOOD COUNT AND CELL POPULATION DATA

EHA Library, Jimin Kahng, 134795

PREVENTION AND TREATMENT OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES - RESULTS FROM A SINGLE HEMATOLOGICAL CENTRE

EHA Library, Gabriella Serke, 134796

EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS OF BLOODSTREAM INFECTIONS IN HEMATOLOGICAL CANCER PATIENTS

EHA Library, Vitalii Chebotkevich, 134797

SIMULTANEOUSLY MONITORING OF SERUM AND URINE CYTOMEGALOVIRUS DNA IN PATIENTS UNDERWENT HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Ying Lu, 134798

MORTALITY PREDICTORS IN PATIENTS WITH BLOOD MALIGNANCIES IN INTENSIVE CARE UNIT AFTER CHEMOTHERAPY.

EHA Library, Bulat Bakirov, 134799

INVASIVE FUNGAL INFECTIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER EXPERIENCE IN TURKEY

EHA Library, Turkan Patıroglu, 134800

EPIDEMIOLOGY AND PROGNOSIS OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES ADMITTED TO INTENSIVE CARE

EHA Library, Regaieg Haifa, 134801

USEFUL CLINICAL FEATURES AND HEMATOLOGICAL PARAMETER FOR THE DIAGNOSIS OF DENGUE INFECTION IN ACUTE FEBRILE ILLNESS PATIENTS

EHA Library, Adisak Tantiworawit, 134802

DIFFERENT WHO SUBTYPES OF CHROMOSOMALLY NORMAL MDS SHARE COMMON AMPLIFIED AREAS ON ACGH/SNPA.

EHA Library, Paolo Bernasconi, 134803

THE ASXL1 GENE ALTERATIONS IN BONE MARROW CELLS OF PATIENTS WITH DELETION 20Q AND MYELOID DISORDERS

EHA Library, Jana Brezinova, 134804

ASSOCIATION BETWEEN POLYMORPHISM OF FOLATE AND METHIONINE METABOLISM RELATED GENES AND ABERRANT DNA METHYLATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Zhanna Sidorova, 134805

DEPLETION OF PROINFLAMMATORY MONOCYTES AND INCREASED LEVELS OF CD56 EXPRESSION ON CLASSICAL MONOCYTES IN THE PERIPHERAL FROM PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Renata Cabral, 134806

PRIMARY RESISTANCE TO AZACYTIDINE IN MDS: PRELIMINARY DATA ON THE POTENTIAL ROLE OF HIF-1A EXPRESSION

EHA Library, Vassiliki Pappa, 134807

PU.1 EXPRESSION CORRELATES WITH PATIENT DISEASE STATUS IN THE MYELODYSPLASTIC SYNDROMES, A NEW PROGNOSTIC MARKER?

EHA Library, Ciro Rinaldi, 134808

MLPA

EHA Library, Dennisse Sharon Toral Ibarra, 134809

CHARACTERIZATION OF THE ERYTHROPOIETIC RESPONSE OF THE DYSPLASTIC MARROW

EHA Library, Marta Pereira, 134810

USEFULNESS OF MUTATIONAL ANALYSIS FOR DIAGNOSIS OF IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE AND MYELODYSPLASTIC SYNDROME

EHA Library, Dong Soon Lee, 134811

THE USAGE OF NEUT-X AND NEUT-Y PARAMETRES IN A ROUTINE HEMATOLOGY LABORATORY AS DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES (MDS )

EHA Library, Panagiota Tsiatsiou, 134812

LOW LEVELS OF CD10, CD11B, CD13, AND CD16 EXPRESSION IN THE PERIPHERAL BLOOD NEUTROPHILS FROM PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Renata Cabral, 134813

MULTIDISCIPLINARY EVALUATION AT BASELINE AND DURING TREATMENT IMPROVES THE RATE OF COMPLIANCE AND EFFICACY OF DEFERASIROX IN ELDERLY MYELODYSPLASTIC PATIENTS.

EHA Library, Lisette Del Corso, 134814

PEPTIDE VACCINATION AGAINST CANCER TESTIS ANTIGENS IN COMBINATION WITH AZACITIDINE FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA: AN ONGOING PHASE I STUDY

EHA Library, Staffan Holmberg, 134815

PROGNOSTIC FACTORS IN CHRONIC MYELOMONOCYTIC LEUKEMIA FROM SOUTH AMERICA

EHA Library, Jacqueline Gonzalez, 134816

SERUM ERYTHROPOIETIN (SEPO) TESTING, LEVELS, AND SUBSEQUENT TREATMENT PATTERNS FOR TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)

EHA Library, Aaron T. Gerds, 134817

IS A 1ST LINE ERYTHROPOIETIN APPROACH IN MYELODYSPLASTIC PATIENTS WITH DEL 5Q- USEFUL?

EHA Library, Paola Volpicelli, 134818

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) SCREENING IN PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) IN CLINICAL PRACTICE: FREQUENCY AND INDICATIONS

EHA Library, Shannon Wong, 134819

COMPASIVE USE OF 5-AZACITIDINE IN PATIENTS WITH LOW/INT-1 RISK MYELODYSPLASTIC SYNDROMES.

EHA Library, Dunia De Miguel Llorente, 134820

A REAPPRAISAL OF THE AZA TREATMENT OUTCOME: ASSESSING THE VALUE OF DISEASE STABILISATION AND EFFECT OF TREATMENT SCHEDULE MODIFICATION

EHA Library, Elena Maria Casartelli, 134821

DIAGNOSTIC VALUE OF PERIODIC ACID-SCHIFF POSITIVITY OF BONE MARROW ERYTHROBLASTS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Rosangela Invernizzi, 134822

NFE2L2,KEAP1AND NQO1GENE EXPRESSION IN MYELODYSPLASTIC SYNDROME AND MONOCLONAL GAMMOPATHIES? CLINICAL IMPLICATIONS

EHA Library, Ana Bela Sarmento-Ribeiro, 134823

BIOSIMILAR ERYTHROPOIETIN ALFA FOR THE THERAPY OF ANEMIA IN ?LOWER RISK? MYELODYSPLASTIC SYNDROMES. INTERIM RESULTS FROM A PROSPECTIVE OBSERVATIONAL STUDY OF THE ?RETE EMATOLOGICA LOMBARDA? (EPOREL)

EHA Library, Anna Maria Pelizzari, 134824

PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES AND THEIR INFLUENCE ON OVERALL SURVIVAL

EHA Library, Tatjana Sotirova, 134825

CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF MYELODYSPLASTIC SYNDROMES (MDS) IN ADULTS ACCORDING TO THE DATA OF MUNICIPAL HEMATOLOGY DEPARTMENTS IN MOSCOW, RUSSIA

EHA Library, Sergey Semochkin, 134826

HIPERFERRITINEMIA IN MYELODISPLASTIC SYNDROME (MSD) PATIENTS.CORELATION WITH EVOLUTION AND SURVIVAL

EHA Library, Hortensia Ionita, 134827

EFFICACY AND SAFETY OF XIAOAIPING TABLETS IN THE TREATMENT OF ELDERLY PATIENTS WITH INTERMEDIATE-RISK/HIGH-RISK MYELODYSPLASTIC SYNDROME: A PILOT TRIAL

EHA Library, Xuemei Sun, 134828

MYELOTOXICITY OF PEPTIDE RECEPTOR RADIONUCLIDE THERAPY OF NEUROENDOCRINE TUMORS: A DECADE OF EXPERIENCE

EHA Library, Murali Kesavan, 134829

ASSESSMENT OF B AND T LYMPHOCYTES FUNCTION IN PATIENTS WITHMYELODYSPLASTIC SYNDROMES

EHA Library, Mohamed Moussa, 134830

DOMICILIARY AZACITIDINE: A NEW EXPERIENCE IN OUR CENTER

EHA Library, Inés Herráez Balanzat, 134831

A RETROSPECTIVE REVIEW OF AZACITIDINE THERAPY IN AN IRISH UNIVERSITY HOSPITAL SETTING

EHA Library, James Nolan, 134832

CLINICAL CHARACTERISTICS, OUTCOME AND PROGNOSTIC FACTORS OF SURVIVAL OF MULTIPLE MYELOMA PATIENTS ACHIEVING AT LEAST VERY GOOD PARTIAL RESPONSE AFTER FIRST LINE TREATMENT IN THE ERA OF NOVEL AGENTS

EHA Library, Evlambia Giannopoulou, 134833

IDENTIFICATION OF PROGNOSTIC RELEVANT GENETIC ABNORMALITIES IN MULTIPLE MYELOMA USING MICROARRAY-BASED GENOMIC PROFILING IN ROUTINE DIAGNOSTICS

EHA Library, Pino Poddighe, 134835

CYR61/CCN1 STIMULATED THE PROLIFERATION AND DIFFERENTIATION OF OSTEOBLASTS IN MYELOMA BONE DISEASE IN VITRO

EHA Library, Rong Fu, 134836

STABLE IN VITRO BORTEZOMIB RESISTANCE OF MYELOMA CELLS IS CHARACTERIZED BY CHROMOSOME 1Q21 COPY NUMBER GAIN

EHA Library, Xenofon Papanikolaou, 134837

ROLE OF EPO IN THE ANGIOGENIC ACTIVITY OF BONE MARROW ENDOTHELIAL CELLS OF MGUS AND MULTIPLE MYELOMA PATIENTS

EHA Library, Domenico Ribatti, 134838

POLYMORPHISM OF IL-10 RECEPTOR ? AFFECTS THE PROGNOSIS OF MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE AND/OR BORTEZOMIB

EHA Library, Tetsuhiro Kasamatsu, 134839

DIETARY HABITS ACROSS THE LIFESPAN AND RISK OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: A POPULATION-BASED SCREENING STUDY

EHA Library, Marianna Thordardottir, 134840

HEAVY-LIGHT CHAIN IMMUNOASSAYS FOR DIAGNOSIS AND MONITORING IGA MULTIPLE MYELOMA: SAVING PITFALLS ON PROTEIN QUANTIFICATION

EHA Library, Marcio Andrade-Campos, 134841

IL-1R AND IL-1RA IN THE DEVELOPMENT OF MULTIPLE MYELOMA

EHA Library, Anastasia Pavlova, 134842

ZOLEDRONIC ACID INHIBITS CELL GROWTH OF MULTIPLE MYELOMA CELLS AND SHOWS SYNERGISTIC ANTIMYELOMA EFFECTS WITH BORTEZOMIB VIA DOWNREGULATION OF PIM-2 THROUGH NF-KB PATHWAY

EHA Library, Rong Fu, 134843

VALIDATION OF REVISED INTERNATIONAL STAGING SYSTEM (R-ISS) IN THE ERA OF NOVEL AGENTS: REAL-WORLD DATA ON 481 MYELOMA PATIENTS FROM A GREEK MYELOMA CENTER

EHA Library, Evlambia Giannopoulou, 134844

THE EFFECT OF HYPOXIA ON NOTCH PATHWAY IN MULTIPLE MYELOMA NICHE

EHA Library, Silvia Garavelli, 134845

A NOVEL TOOL TO MONITOR ANGIOGENESIS IN BONE MARROW SMEARS: DETECTION AND QUANTIFICATION OF ENDOTHELIAL PROGENITOR CELLS BY MULTIPLE-LABELING IMMUNOFLUORESCENCE ANALYSIS

EHA Library, Maria Tenreiro, 134846

THE EFFECT OF MIR-146A OVEREXPRESSION ON THE PROLIFERATION AND APOPTOSIS OF MULTIPLE MYELOMA CELL LINE

EHA Library, Shima Kazemzadeh, 134847

MAST CELLS INDUCE MYELOMA PLASMA CELLS? PROLIFERATION

EHA Library, Georgios Tsirakis, 134848

EARLY DETECTION OF PLASMA CELL DYSCRASIA IN SERUM PROTEIN ELECTROPHORESIS

EHA Library, Manuela rebordao, 134849

SERUM LEVELS OF E-SELECTIN AND VCAM-1 IN ACTIVE MYELOMA

EHA Library, Georgios Tsirakis, 134850

RISK FACTORS ASSOCIATED WITH EARLY MORTALITY IN PATIENTS WITH MULTIPLE MYELOMA IN THE NOVEL-AGENTS ERA

EHA Library, Sung-Hoon Jung, 134851

EXPECTANCY OF LIFE AND INCIDENCE RATE OF NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS. 15 YEARS RETROSPECTIVE ANALYSIS

EHA Library, FERNANDO ESCALANTE BARRIGON, 134852

IMPACT OF TIME SPENT WAITING FOR AUTOLOGOUS TRANSPLANTATION ON THE OUTCOME OF PATIENTS WITH MULTIPLE MYELOMA.

EHA Library, Francesco Ripamonti, 134853

SINGLE CENTRE OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA.

EHA Library, Tom Rider, 134854